Continuous β-Amyloid CSF/PET Imbalance Model to Capture Alzheimer Disease Heterogeneity.
Mastenbroek SE, Sala A, Vállez García D, Shekari M, Salvadó G, Lorenzini L, Pieperhoff L, Wink AM, Lopes Alves I, Wolz R, Ritchie C, Boada M, Visser PJ, Bucci M, Farrar G, Hansson O, Nordberg AK, Ossenkoppele R, Barkhof F, Gispert JD, Rodriguez-Vieitez E, Collij LE; Alzheimer's Disease Neuroimaging Initiative on behalf of the AMYPAD consortium.
Mastenbroek SE, et al.
Neurology. 2024 Jul 9;103(1):e209419. doi: 10.1212/WNL.0000000000209419. Epub 2024 Jun 11.
Neurology. 2024.
PMID: 38862136
Free PMC article.
METHODS: Across 822 cognitively unimpaired (n = 261) and cognitively impaired (n = 561) Alzheimer's Disease Neuroimaging Initiative individuals (384 [46.7%] females, mean age 73.0 7.4 years), we fitted baseline CSF-Abeta(42) and global Abeta-PET to a hyperbolic regression …
METHODS: Across 822 cognitively unimpaired (n = 261) and cognitively impaired (n = 561) Alzheimer's Disease Neuroimaging Initiative i …